Literature DB >> 23018243

Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma.

Jin Hwa Choi1, Na Ri Shin, Hyun Jung Moon, Chae Hwa Kwon, Gwang Ha Kim, Geun Am Song, Tae Yong Jeon, Dae Hwan Kim, Dong Hun Kim, Do Youn Park.   

Abstract

With increasing therapeutic use of minimally invasive therapy for treatment of early gastric cancer, prediction of lymph node metastasis is important. In search of tissue biomarkers for prediction of lymph node metastasis of gastric adenocarcinoma, we analyzed gastric adenocarcinoma tissue using proteomic methods. We have done 2D-PAGE and MALDI-TOF MS analysis in matched normal and gastric cancer tissues. We also evaluated the clinicopathological significance of expression of S100A8 and S100A9 in gastric adenocarcinoma using a tissue microarray of 218 gastric adenocarcinoma specimens. Cell invasion and migration assay were performed to confirm functional role of S100A8 and S100A9 using small hairpin RNA lentivirus. We identified 8 up-regulated and 5 down-regulated proteins in gastric cancer tissues compared to matched normal mucosa. Of these, expression of S100A8 and S100A9 occurred mainly in stromal cells and inflammatory cells between tumor cells. Correlation was observed between small lesion size, decreased depth of invasion, a tendency to absence of lymphovascular tumor emboli, a decrease in perineural invasion and lymph node metastasis, and expression of stromal S100A8. In addition, increased expression of stromal S100A9 in gastric adenocarcinoma was associated with small lesion size and a decrease in lymph node metastasis. Functional analysis confirmed that down-regulation of S100A8 and S100A9 by small hairpin RNA lentivirus induced an increase of migration and invasion in gastric cancer cell lines. Taken together, these findings suggest that S100A8 and S100A9 are negative regulators of lymph node metastasis of gastric adenocarcinoma and can be used as biomarkers for prediction of lymph node metastasis in gastric adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018243     DOI: 10.14670/HH-27.1439

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  11 in total

1.  Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3.

Authors:  Bibo Tan; Yong Li; Qun Zhao; Liqiao Fan; Dong Wang; Yü Liu
Journal:  Tumour Biol       Date:  2013-09-27

2.  CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9.

Authors:  Yuwei Zhang; Fengping Liu; Yangkun Feng; Xinyu Xu; Yang Wang; Sha Zhu; Jian Dong; Shanchao Zhao; Bin Xu; Ninghan Feng
Journal:  Cancer Gene Ther       Date:  2022-06-27       Impact factor: 5.987

3.  Protein S100-A8: A potential metastasis-associated protein for breast cancer determined via iTRAQ quantitative proteomic and clinicopathological analysis.

Authors:  Jing-Min Zhong; Jing Li; An-Ding Kang; San-Qian Huang; Wen-Bin Liu; Yun Zhang; Zhi-Hong Liu; Liang Zeng
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

4.  S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.

Authors:  Chae Hwa Kwon; Hyun Jung Moon; Hye Ji Park; Jin Hwa Choi; Do Youn Park
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

5.  ID1 promotes breast cancer metastasis by S100A9 regulation.

Authors:  Kiranmai Gumireddy; Anping Li; Andrew V Kossenkov; Kathy Q Cai; Qin Liu; Jinchun Yan; Hua Xu; Louise Showe; Lin Zhang; Qihong Huang
Journal:  Mol Cancer Res       Date:  2014-06-19       Impact factor: 5.852

6.  Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.

Authors:  Ionela Daniela Popescu; Elena Codrici; Lucian Albulescu; Simona Mihai; Ana-Maria Enciu; Radu Albulescu; Cristiana Pistol Tanase
Journal:  Proteome Sci       Date:  2014-09-24       Impact factor: 2.480

7.  Potential Role of S100A8 in Cutaneous Squamous Cell Carcinoma Differentiation.

Authors:  Jung-Min Shin; In-Kyu Chang; Young-Ho Lee; Min-Kyung Yeo; Jin-Man Kim; Kyung-Cheol Sohn; Myung Im; Young-Joon Seo; Chang-Deok Kim; Jeung-Hoon Lee; Young Lee
Journal:  Ann Dermatol       Date:  2016-03-31       Impact factor: 1.444

8.  Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).

Authors:  André P Nicklas; Mario W Kramer; Jürgen Serth; Jörg Hennenlotter; Marie C Hupe; Daniel U Reimer; Arnulf Stenzl; Axel S Merseburger; Markus A Kuczyk; Christoph-Alexander J von Klot
Journal:  Adv Ther       Date:  2018-09-19       Impact factor: 3.845

9.  High S100A9+ cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection.

Authors:  Jing Liao; Jin-Zhu Li; Jing Xu; Yongquan Xu; Wei-Ping Wen; Limin Zheng; Lian Li
Journal:  Aging (Albany NY)       Date:  2021-06-22       Impact factor: 5.682

10.  Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.

Authors:  Ali Khammanivong; Brent S Sorenson; Karen F Ross; Erin B Dickerson; Rifat Hasina; Mark W Lingen; Mark C Herzberg
Journal:  Oncotarget       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.